Kolon Life Science Inc. (KOSDAQ:102940)
South Korea
· Delayed Price · Currency is KRW 25,150
-1,550 (-5.81%)
Feb 21, 2025, 3:30 PM KST
Kolon Life Science Revenue
Kolon Life Science had revenue of 35.92B KRW in the quarter ending September 30, 2024, with 27.31% growth. This brings the company's revenue in the last twelve months to 147.98B, up 13.52% year-over-year. In the year 2023, Kolon Life Science had annual revenue of 124.64B, down -22.86%.
Revenue (ttm)
147.98B
Revenue Growth
+13.52%
P/S Ratio
1.99
Revenue / Employee
352.33M
Employees
420
Market Cap
312.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
| Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
| Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
| Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
| Dec 31, 2019 | 148.54B | 7.29B | 5.16% |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 57.73T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Celltrion | 2,876.25B |
| Kia Corporation | 104.63T |
| NAVER | 10.39T |